News
Green Bioactives awarded prestigious Innovate UK grant to develop revolutionary biomanufacturing platform
Green Bioactives (GBL), a world-leader in the discovery, development and sustainable production of high-value natural products using its proprietary plant cell culture technology, announced that it has been awarded a significant grant from Innovate UK, in partnership with the University of Edinburgh
New laboratory assays to measure functional immunity in fish
Moredun Scientific are now able to offer a range of laboratory assays to measure functional immunity in fish and can be used for a variety of purposes such as assessing the potency of vaccines and vaccine protocols and measuring the effect of functional feed and feed additives on the fish immune system.
Veterinary diagnostics spin-out raises $4 million
A Scottish veterinary diagnostics has secured $4m in Series A funding.
MI:RNA is aiming to change the future of animal health treatments through earlier diagnostics. The new capital will be used to continue global growth plans.
A model for the future by The Energy Training Academy
Midlothian Science Zone Business Forum visited the new community-focussed Energy Training Academy in Eskbank to learn about this amazing training facility, empowering a sustainable future through renewable energy education and showcasing a Net Zero Home.
Midlothian-based start-up crowned Scotland’s ‘most exciting tech business’
Midlothian Science Zone-based biotech, OGI-Bio, has been selected to represent Scotland in the search for the best of UK tech in KPMG finals.
Moredun Research Institute awarded grant to tackle resistance to sheep scab treatments
The Moredun Research Institute, in collaboration with leading partners, has been awarded a £1.2M grant to explore the mechanism of resistance to the macrocyclic lactone (ML) injectables in the sheep scab mite, Psoroptes ovis.
Midlothian biotech receives £650,000 follow-on investment
OGI Bio’s advanced bioreactors and automated systems streamline microbial growth, optimising product development in diverse sectors. The funding will accelerate expansion in the UK, EU, and US biotechnology sectors.